New Publication (2016)
Kawasaki Disease: Current Understanding of the Mechanism and Evidence-Based Treatment, 1st ed. 2017 Edition (Informational flyer: KDbook_Saji2016_flyer.pdf )
Published KD articles
- 2014 Lancet: Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
- (Adult KD) 2017 Global Cardiology: Management of sequelae of Kawasaki (Portuguese translation)
Possible cause of Kawasaki disease found
More information about possible cause and source of Kawasaki disease found, and published by the
press release from UCSD.
2018 Kawasaki Disease Parent Symposium
Thank you to all who
attended the 2018 KD Parent Symposium last September 29, 2018 and to the
KD Foundation for sponsoring the event. If
you were unable to attend in person or participate in the live event on
Facebook, you may view the videos using the links below.
* Eczema and KD:
There is a link between eczema, a genetic condition, and KD which has a
genetic basis for susceptibility. It is very common to see eczema in KD
* KD and African American children:
The genetic susceptibility is higher in African Americans more than
Caucasian and Latinos in the US. More research is needed to understand
the overrepresentation of African Americans in KD.
* CT Calcium Score:
The UCSD team is only recommending the score for patients who have had dilation or aneurysms of the coronary artery or for whom the results of the initial echo is unknown.
* Vaccines and KD:
Panels have been appointed by the vaccine companies to adjudicate
relationship between a vaccine and subsequent KD and the expert panels
found no relationship. The CDC has also published a paper looking at
KD/vaccine relationships, and none was found.
SAVE THE DATE: 2019 Kawasaki Disease Parent Symposium
Date: Saturday, October 19, 2019
Time: 9:00 AM - 12:00 PM
Venue: Telemedicine Building Auditorium, UC San Diego, 9500 Gilman Dr, La Jolla, CA 92093
Contact: Email firstname.lastname@example.org to join the KD mailing list.